← Mirum
What podcasts say about Mirum
Every statement, with the speaker, the exact quote and the moment it was said.
What experts have said about Mirum
5 statements · 5 positive
Mirum is expected to generate over $700 million in marketed-franchise sales this year.
“The company is going to sell about 700 plus million dollars of sales this year in their marketed franchise.”
Open the episode · The Quality Growth Playbook for Biotech | David FerreiroListen at 10:12
Mirum's PSC opportunity could address 20,000 patients starting next year.
“this could be a 20,000 patient market opportunity that could start for them next year”
Open the episode · The Quality Growth Playbook for Biotech | David FerreiroListen at 11:44
Mirum acquired an FOP opportunity worth $200 million for under $100 million including milestones.
“$200 million opportunity that they basically paid something less than $100 million after you tie in all the milestones.”
Open the episode · The Quality Growth Playbook for Biotech | David FerreiroListen at 12:35
Mirum has a strong, steadily growing commercial business.
“they have a pretty strong commercial business that's been growing pretty readily”
Open the episode · The Quality Growth Playbook for Biotech | David FerreiroListen at 12:48
Mirum's pipeline appears substantially undervalued relative to its commercial business.
“we think we're getting a pretty substantial discount on the pipeline that they've built”
Open the episode · The Quality Growth Playbook for Biotech | David FerreiroListen at 26:57
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.